These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
149 related articles for article (PubMed ID: 23747134)
21. Retrospective study on clinical value and optimal use of [ Kobayashi T; Miyamori D; Ito M Sci Rep; 2024 Nov; 14(1):28197. PubMed ID: 39548274 [TBL] [Abstract][Full Text] [Related]
22. Diagnostic ability of [ Lee DY; Kim YI; Ryu JS Eur Radiol; 2025 Jan; 35(1):479-486. PubMed ID: 39026061 [TBL] [Abstract][Full Text] [Related]
23. Ruan D; Sun J; Han C; Cai J; Yu L; Zhao L; Pang Y; Zuo C; Sun L; Wang Z; Tan G; Qu X; Chen H Theranostics; 2024; 14(18):6935-6946. PubMed ID: 39629119 [No Abstract] [Full Text] [Related]
24. Early prediction of radiotherapy outcomes in pharyngeal cancer using deep learning on baseline [18F]Fluorodeoxyglucose positron emission Tomography/Computed tomography. Wu KC; Chen SW; Chang RF; Hsieh TC; Yen KY; Chang CJ; Hsu ZK; Yeh YC; Chang YY; Kao CH Eur J Radiol; 2024 Dec; 181():111811. PubMed ID: 39488888 [TBL] [Abstract][Full Text] [Related]
25. Personalised PET imaging in oncology: an umbrella review of meta-analyses to guide the appropriate radiopharmaceutical choice and indication. Kirienko M; Gelardi F; Fiz F; Bauckneht M; Ninatti G; Pini C; Briganti A; Falconi M; Oyen WJG; van der Graaf WTA; Sollini M Eur J Nucl Med Mol Imaging; 2024 Dec; 52(1):208-224. PubMed ID: 39256216 [TBL] [Abstract][Full Text] [Related]
26. Impact of residual disease as a prognostic factor for survival in women with advanced epithelial ovarian cancer after primary surgery. Bryant A; Hiu S; Kunonga PT; Gajjar K; Craig D; Vale L; Winter-Roach BA; Elattar A; Naik R Cochrane Database Syst Rev; 2022 Sep; 9(9):CD015048. PubMed ID: 36161421 [TBL] [Abstract][Full Text] [Related]
27. Prediction of Prognosis and Response to Androgen Deprivation Therapy in Intermediate to High-Risk Prostate Cancer Using Qiao J; Liu B; Xin J; Shen S; Ma H; Pan S Acad Radiol; 2024 Dec; 31(12):5008-5021. PubMed ID: 39019687 [TBL] [Abstract][Full Text] [Related]
28. Direct comparison of the diagnostic accuracy of 2-[ Ko WS; Kim SJ Clin Radiol; 2024 Feb; 79(2):142-149. PubMed ID: 37968227 [TBL] [Abstract][Full Text] [Related]
29. 18F-FDG PET/CT for early prediction of pathological complete response in breast cancer neoadjuvant therapy: a retrospective analysis. Wu Y; Li Y; Chen B; Zhang Y; Xing W; Guo B; Wang W Oncologist; 2024 Dec; 29(12):e1646-e1655. PubMed ID: 39045652 [TBL] [Abstract][Full Text] [Related]
30. [ Chang Y; Gu Y; Ruan S; Xu S; Sun J; Jiang Z; Yao G; Wang Z; Zhao H Cancer Imaging; 2024 Nov; 24(1):160. PubMed ID: 39582078 [TBL] [Abstract][Full Text] [Related]
31. Improved Prognosis of Treatment Failure in Cervical Cancer with Nontumor PET/CT Radiomics. Yusufaly TI; Zou J; Nelson TJ; Williamson CW; Simon A; Singhal M; Liu H; Wong H; Saenz CC; Mayadev J; McHale MT; Yashar CM; Eskander R; Sharabi A; Hoh CK; Obrzut S; Mell LK J Nucl Med; 2022 Jul; 63(7):1087-1093. PubMed ID: 34711618 [TBL] [Abstract][Full Text] [Related]
32. Rate of benign nodule resection in a lung cancer screening program. El Alam R; Byrne SC; Hammer MM Clin Imaging; 2023 Dec; 104():109984. PubMed ID: 37832324 [TBL] [Abstract][Full Text] [Related]
33. Performance of fibroblast activating protein inhibitor PET imaging for pancreatic neoplasms assessment: a systematic review and meta-analysis. Tang R; Liu M; Shu Q; Chen X; Cai L Eur Radiol; 2024 Dec; 34(12):7804-7812. PubMed ID: 38907099 [TBL] [Abstract][Full Text] [Related]
35. Identifying the primary tumour in patients with cancer of unknown primary (CUP) using [ Willemse JRJ; Lambregts DMJ; Balduzzi S; Schats W; Snaebjornsson P; Marchetti S; Vollebergh MA; van Golen LW; Cheung Z; Vogel WV; Bodalal Z; Rostami S; Gerke O; Sivakumaran T; Beets-Tan RGH; Lahaye MJ Eur J Nucl Med Mol Imaging; 2024 Dec; 52(1):225-236. PubMed ID: 39141069 [TBL] [Abstract][Full Text] [Related]
36. Diagnostic role of PET or PET/CT for prosthetic joint infection: A systematic review and Meta-analysis. Kim K; Kim SJ Hell J Nucl Med; 2021; 24(1):83-93. PubMed ID: 33866342 [TBL] [Abstract][Full Text] [Related]
37. Circulating tumour DNA-Based molecular residual disease detection in resectable cancers: a systematic review and meta-analysis. Zheng J; Qin C; Wang Q; Tian D; Chen Z EBioMedicine; 2024 May; 103():105109. PubMed ID: 38614009 [TBL] [Abstract][Full Text] [Related]
38. Prostate Magnetic Resonance Imaging Using the Prostate Imaging for Recurrence Reporting (PI-RR) Scoring System to Detect Recurrent Prostate Cancer: A Systematic Review and Meta-analysis. Mourato FA; Schmitt LG; Mariussi M; Torri G; Altmayer S; Giganti F; Abreu-Gomez J; Perlis N; Berlin A; Ghai S; Haider MA; Dias AB Eur Urol Oncol; 2024 Dec; 7(6):1246-1254. PubMed ID: 38824004 [TBL] [Abstract][Full Text] [Related]
39. Pre-procedure Jin AF; Luo ZH; Qi WL; Liu Q Diagn Interv Radiol; 2024 Nov; 30(6):380-384. PubMed ID: 38293844 [TBL] [Abstract][Full Text] [Related]
40. Detection of tumour heterogeneity in patients with advanced, metastatic castration-resistant prostate cancer on [ Pabst KM; Mei R; Lückerath K; Hadaschik BA; Kesch C; Rawitzer J; Kessler L; Bodensieck LS; Hamacher R; Pomykala KL; Fanti S; Herrmann K; Fendler WP Eur J Nucl Med Mol Imaging; 2024 Dec; 52(1):342-353. PubMed ID: 39207485 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]